Background The glucagon-like peptide-1 (GLP-1) is a multifaceted hormone with broad
pharmacological potential. Among the numerous metabolic effects of GLP-1 are the glucose …

Abstract Glucagon‐like peptide‐1 (GLP‐1) is secreted by intestinal L‐cells following food
intake, and plays an important role in glucose homeostasis due to its stimulation of glucose …

Glucagon-like peptide (GLP)-1 is an incretin hormone with potent glucose-dependent
insulinotropic and glucagonostatic actions, trophic effects on the pancreatic β-cells, and …

The incretin hormone, glucagon-like peptide 1 (GLP-1) has many actions; namely:(1) it
enhances all steps of insulin biosynthesis and potentiates glucose-induced secretion;(2) it …

Glucagon-like peptide-1 (GLP-1), an incretin hormone secreted primarily from the intestinal
L-cells in response to meals, modulates nutrient homeostasis via actions exerted in multiple …

Post‐translational proteolytic processing of the preproglucagon gene in the gut results in the
formation of glucagon‐like peptide 1 (GLP‐1). Owing to its glucose‐dependent …

Glucagon‐like peptide 1 (GLP‐1) is a gut‐derived incretin hormone with the potential to
change diabetes. The physiological effects of GLP‐1 are multiple, and many seem to …

Type 2 diabetes is increasingly becoming a worldwide epidemic. Currently there is much
focus on the glucagon-like peptide-1 (GLP-1) peptide hormone as the basis for a potential …

The incretin hormone, glucagon-like peptide-1 (GLP-1), is now being used in the clinic to
enhance insulin secretion and reduce body weight in patients with type 2 diabetes. Although …

The glucagon-like peptides (glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2
(GLP-2)) are released from enteroendocrine cells in response to nutrient ingestion. GLP-1 …